HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vasculogenic Impotence

Inability to achieve and maintain an erection (ERECTILE DYSFUNCTION) due to defects in the arterial blood flow to the PENIS, defect in venous occlusive function allowing blood drainage (leakage) from the erectile tissue (corpus cavernosum penis), or both.
Also Known As:
Impotence, Vasculogenic; Arteriogenic Impotence; Leakage, Penile Venous; Penile Venous Leakage; Venogenic Impotence; Impotence, Arteriogenic; Impotence, Venogenic; Venous Leakage, Penile
Networked: 99 relevant articles (5 outcomes, 12 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Erectile Dysfunction
2. Penile Induration (Peyronie's Disease)
3. Vascular Diseases (Vascular Disease)
4. Ulcer
5. Pain (Aches)

Experts

1. Aronow, Wilbert S: 5 articles (09/2010 - 02/2004)
2. Nunes, L: 2 articles (06/2002 - 08/2001)
3. Lue, T F: 2 articles (06/2002 - 08/2001)
4. Cayan, Selahittin: 1 article (09/2008)
5. Shamloul, Rany: 1 article (05/2007)
6. Arafa, Mohamed: 1 article (05/2007)
7. Eid, Hazem: 1 article (05/2007)
8. Padmanabhan, Priya: 1 article (03/2007)
9. McCullough, Andrew R: 1 article (03/2007)
10. Lafuente-de-Carvalho, José-Maria: 1 article (10/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Vasculogenic Impotence:
1. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
2. Testosterone (Sustanon)FDA Link
3. Nitric Oxide Synthase (NO Synthase)IBA
4. Follicle Stimulating Hormone (Follitropin)FDA Link
5. CreatinineIBA
6. 11-dehydro-thromboxane B2IBA
7. PapaverineIBA
8. Alprostadil (Muse)FDA LinkGeneric
9. Phentolamine (Z-Max)FDA LinkGeneric
10. AdenosineFDA LinkGeneric

Therapies and Procedures

1. Angioplasty (Angioplasty, Transluminal)
2. Ligation
3. Transplants (Transplant)
4. Injections
5. Limb Salvage
09/01/2010 - "Indications for lower-extremity angioplasty, preferably with stenting, or bypass surgery are incapacitating claudication interfering with work or lifestyle in patients; limb salvage in patients with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, infection, or gangrene; and vasculogenic impotence."
01/01/2007 - "Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in patients interfering with work or lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene; and (3) vasculogenic impotence."
01/01/2007 - "Indications for lower extremity percutaneous transluminal angioplasty or bypass surgery are (1) incapacitating claudication in persons interfering with work or lifestyle, (2) limb salvage in persons with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene, and (3) vasculogenic impotence."
03/01/2005 - "Indications for lower-extremity angioplasty, preferably with stenting, or bypass surgery are 1) incapacitating claudication in persons interfering with work or lifestyle; 2) limb salvage in persons with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene; and 3) vasculogenic impotence. "
02/01/2004 - "Indications for lower extremity angioplasty, preferably with stenting, or bypass surgery are 1) incapacitating claudication in persons interfering with work or lifestyle; 2) limb salvage in persons with limb-threatening ischemia as manifested by rest pain, nonhealing ulcers, and/or infection or gangrene; and 3) vasculogenic impotence. "